MCRB – seres therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

MCRB

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/6

06:36 pm

mcrb

Seres Therapeutics: Strong SER-155 Data, But Dilution Risk Now Warrants A 'Hold' [Seeking Alpha]

Low Report

Seres Therapeutics: Strong SER-155 Data, But Dilution Risk Now Warrants A 'Hold' [Seeking Alpha]

Report

1/6

07:00 am

mcrb

Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy

Low Report

Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy

Report

11/24

07:00 am

mcrb

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

Medium Report

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

Report

11/18

01:20 pm

mcrb

Seres Therapeutics (NASDAQ:MCRB) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.

High Report

Seres Therapeutics (NASDAQ:MCRB) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.